SCHEMBL4979429

SCHEMBL4979429

O=C(CO)n1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18787369 0.79 FBP1 (0.33) —
SCHEMBL23611391 0.79 FBP1 (0.33) —
SCHEMBL28801587 0.74 — —
SCHEMBL5065336 0.74 — —
SCHEMBL4376441 0.74 — —
SCHEMBL10784064 0.74 — —
SCHEMBL11572551 0.74 — —
SCHEMBL10676122 0.74 — —
SCHEMBL9853841 0.74 — —
SCHEMBL27582678 0.74 CAMK2A (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459044-A Tank-binding kinase inhibitor compounds 吉利德科学公司 2017-02-22 — — CN disclosed
US-9220827-B2 Apparatus for extracorporeal blood treatment B. BRAUN AVITUM AG (DE) 2015-12-29 — — US disclosed
US-20130237896-A1 APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT B. BRAUN AVITUM AG (DE) 2013-09-12 — — US disclosed
WO-2008016643-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 — — WO disclosed
EP-1257272-A4 THIAZOLIUM COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON INC (US) 2004-12-15 — — EP disclosed
EP-1248615-A4 THIAZOLE, IMIDAZOLE AND OXAZOLE COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON INC (US) 2004-08-04 — — EP disclosed
EP-1303501-A4 CYANOMETHYL SUBSTITUTED THIAZOLIUMS AND IMIDAZOLIUMS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON INC (US) 2004-03-03 — — EP disclosed
WO-2003102007-A1 PROCESS FOR SYNTHESISING C-GLYCOSIDES THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2003-12-11 — — WO disclosed
EP-1303501-A1 CYANOMETHYL SUBSTITUTED THIAZOLIUMS AND IMIDAZOLIUMS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING Alteon, Inc. (US) 2003-04-23 — — EP disclosed
EP-1257272-A1 THIAZOLIUM COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING Alteon, Inc. (US) 2002-11-20 — — EP disclosed
WO-2001052847-A1 THIAZOLE, IMIDAZOLE AND OXAZOLE COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON, INC. (US) 2001-07-26 — — WO disclosed
EP-1104412-A1 TACE INHIBITORS Pfizer Products Inc. (US) 2001-06-06 — — EP disclosed
WO-2000009492-A1 TACE INHIBITORS PFIZER PRODUCTS INC. (US) 2000-02-24 — — WO disclosed
WO-1996040663-A1 DI- AND TRI-AMINOGUANIDINES AND THEIR USE TO INHIBIT THE ADVANCED GLYCOSYLATION OF PROTEINS ALTEON INC. (US) 1996-12-19 — — WO disclosed
EP-0566698-A1 AMINO-SUBSTITUTED PYRIMIDINES, DERIVATIVES AND METHODS OF USE THEREFOR THE ROCKEFELLER UNIVERSITY (US) 1993-10-27 — — EP disclosed
WO-1993013775-A1 DIAMINOPYRIDINE COMPOUNDS FOR THE INHIBITION OF PROTEIN GLYCOSYLATION THE ROCKEFELLER UNIVERSITY (US) 1993-07-22 — — WO disclosed
WO-1992019236-A1 2-ALKYLIDENE-AMINOGUANIDINES FOR INHIBITING ADVANCED NONENZYMATICGLYCOSYLATION OF PROTEINS THE ROCKEFELLER UNIVERSITY (US) 1992-11-12 — — WO disclosed
WO-1992014704-A1 2-SUBSTITUTED-2-IMIDAZOLINES THE ROCKEFELLER UNIVERSITY (US) 1992-09-03 — — WO disclosed
WO-1992011853-A1 AMINO-SUBSTITUTED PYRIMIDINES, DERIVATIVES AND METHODS OF USE THEREFOR THE ROCKEFELLER UNIVERSITY (US) 1992-07-23 — — WO disclosed
WO-1992007560-A1 BIGUANIDES AND DERIVATIVES THEREOF AS INHIBITORS OF ADVANCED GLYCOSYLATION OF A TARGET PROTEIN THE ROCKEFELLER UNIVERSITY (US) 1992-05-14 — — WO disclosed
Send feedback